BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $18,623,000 | +16.4% | 367,537 | -8.1% | 1.13% | +9.2% |
| Q1 2017 | $15,996,000 | +1855.5% | 400,000 | +1352.5% | 1.04% | +1496.9% |
| Q3 2016 | $818,000 | +42.5% | 27,539 | -2.9% | 0.06% | +18.2% |
| Q2 2016 | $574,000 | +17.6% | 28,353 | +4.8% | 0.06% | +10.0% |
| Q1 2016 | $488,000 | -93.3% | 27,055 | -90.2% | 0.05% | -90.8% |
| Q4 2015 | $7,288,000 | -7.1% | 276,687 | -24.7% | 0.54% | -8.2% |
| Q3 2015 | $7,842,000 | -18.9% | 367,485 | -2.8% | 0.59% | -25.1% |
| Q2 2015 | $9,671,000 | – | 378,235 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |